维普期刊资源整合服务平台（V6.5）

维普中文期刊产品整合服务

19篇 您的检索式：作者名="Gunaldi"

选中清除导出查看参考文献查看引证文献引用追踪共1页首页上一页第1页下一页末页 /1 跳转

		题名	作者	年代	出处	被引量
	1	Cervical segment nervus vagus neurofibroma with associated neurofibromatosis type Ⅰ:a case report显示文摘	Guler AK Gunaldi O Alis H		0，，：	1
	2	Utility of peripheral blood parameters in predicting breast cancer risk显示文摘	Okuturlar Y Gunaldi M Tiken EE	2015	Asian Pac J Cancer Prev2015，16，6：	1
	3	A new approach to the treatment of metastatic paraganglioma:sorafenib显示文摘	GUNALDI M KARA I O DUMAN B B	2014	Cancer Res Treat2014，46，4：	1
	4	Efficacy of clinical prog- nostic factors on survival in patients with glioblastoma 显示文摘	Tugcu B Postalci LS Gunaldi O	2010	Turk Neurosurg2010，20，2：	1
	5	Coexistence of tuberous sclerosis complex and malignant melanoma显示文摘	Gunaldi M Paydas S Afsar CU	2013	Singapore Med J2013，54，11：	1
	6	Efficacy of clinical prognostic factors on survival in patients with glioblastoma 显示文摘	Tugcu B Postalci LS Gunaldi O	2010	Turk Neurosurg2010，20，3：	1
	7	Efficacy of clinical prognostic factors on survival in patients with glioblasto-ma显示文摘	Tugcu B Postalci LS Gunaldi O		0，，3：	1
	8	Coexistence of tuberous sclerosis complex and malignant melanoma 显示文摘	Gunaldi M Paydas S Afsar C U	2013	Singapore Med J2013，54，11：	1
	9	Lymphocytic hypo- physitis: an underestimated disease affecting the sellar region 显示文摘	Tugcu B Gunaldi O Postalci L	2011	Neurol Neurochir Pol2011，45，2：	1
	10	Efficacy of clinical prognostic factors on survival in patients with glioblastoma显示文摘	Tugeu B Postalei LS Gunaldi O	2010	Turk Neurosurg2010，20，2：	1
	11	Efficacy of clinical prognostic factors on survival in patients with glioblasto-ma显示文摘	Tugcu B Postalci LS Gunaldi O		0，，2：	1
	12	Primary intracerebral myeloid sarcoma显示文摘	Gunaldi M Kara IO Duman BB		0，，11：	1
	13	Primary intracerebral myeloid sarcoma 显示文摘	Gunaldi M Kara IO Duman BB	2012	Onkologie2012，35，11：	1
	14	'Honey' can prevent epidural fibrosis development after laminectomy : an experimental study 显示文摘	Gunaldi O Erdogan S Guclu DG	2014	Turk Neurosurg2014，24，6：	1
	15	Retrospective analysis of 498 primary soft tissue sarcomas in a single Turkish centre 显示文摘	Duman BB Gunaldi M Ercolak V	2012	Asian Pac J Cancer Prev2012，13，8：	1
	16	Prognostic impact of plate- let/lymphocyte and neutrophil/lymphocyte ratios in patients with gastric cancer: a multieenter study 显示文摘	Gunaldi M Goksu S Erdem D	2015	Int J Clin Exp Med2015，8，4：	1
	17	Efficacy of clinical prognostic factors on survival in patients with gliobastoma显示文摘	Tugcu B Postalci LS Gunaldi O	2010	Turk Neurosurg2010，20，2：	1
	18	Efficacy of clinical prognos- tic factors on survival in patients with glioblastoma显示文摘	Tugcu B Postalci LS Gunaldi O	2010	Turk Neuro- surg2010，20，2：	1
	19	Impact of sorafenib on epidural fibrosis: An immunohistochemical study显示文摘AIM To determine if sorafenib, an antineoplastic agent, could prevent the development of spinal epidural fibrosis(EF). METHODS The study used CD105 and osteopontin antibodiesin an immunohistochemical approach to quantify EF that occurred as a consequence of laminectomy in rats. Wistar albino rats(n = 16) were divided into two groups: control(L1-2 level laminectomy only) and sorafenib treatment(L1-2 level laminectomy + topical sorafenib). The animals were euthanatized after 6 wk, and the EF tissues were examined for histopathological changes after immunohistochemical staining. The EF grades were assigned to the tissues, and the treatment and control groups were compared. RESULTS The EF thickness, inflammatory cell density, and arachnoid adherences determined by light microscopy were significantly higher in the control group compared to the sorafenib-treated group. Based on fibrosis scores, the extent of EF in the treatment group was significantly lower than in the controls. Immunohistochemical staining for CD105 to identify microvessels revealed that the EF grades based on vessel count were significantly lower in the treatment group. Staining for osteopontin did not show any significant differences between the groups in terms of the extent of EF. The staging of EF based on vascular counts observed after immunohistochemical staining for CD105, but not for osteopontin, was compatible with conventional staging methods. Neither toxic effects on tissues nor systemic side effects were observed with the use of sorafenib. CONCLUSION Local administration of sorafenib significantly reduced post-laminectomy EF. Decreased neovascularization in spinal tissue may be due to the sorafenib-induced inhibition of vascular endothelial growth factor.	Osman Tanriverdi Uzay Erdogan Canan Tanik Ilhan Yilmaz Omur Gunaldi Huseyin Utku Adilay Ayca Arslanhan Metehan Eseoglu	2018	World Journal of Clinical Cases2018，6，9：	0

返回顶部每页显示：

共1页首页上一页第1页下一页末页 /1 跳转

goolge学术搜索-维普

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1　渝公网安备 50019002500403号　违法和不良信息举报中心

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费